Forkhead box P3 and indoleamine 2,3-dioxygenase co-expression in Pakistani triple negative breast cancer patients

doi:10.5306/wjco.v11.i12.1018

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 12

This Article

(230)

(201)

(0)

(10)

(4483)

(5)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Retrospective Study

World J Clin Oncol. Dec 24, 2020; 11(12): 1018-1028
Published online Dec 24, 2020. doi: 10.5306/wjco.v11.i12.1018

Table 1 Baseline characteristics of breast cancer patients

Variables	Levels	Total, n %
Age	mean ± SD	48.28 ± 11.83
Region	Punjab	88 (88.0%)
	Khyber Pakhtunkhwa	7.0 (7.0%)
	Kashmir	3.0 (3.0%)
	Sindh	2.0 (2.0%)
Histology	Ductal	91 (91.0%)
	Others	9.0 (9.0%)
Grade	II	35 (35.0%)
	III	56 (56.0%)
	UNK	09 (9.0%)
Tumor size	T1	7.0 (7.0%)
	T2/T3	57 (57.0%)
	UNK	36 (36.0%)
Nodes	Negative	37 (37.0%)
	Positive	50 (50.0%)
	UNK	13 (13.0%)
Metastasis	Negative	38 (38.0%)
	Positive	49 (49.0%)
	UNK	13 (13.0%)
Estrogen receptor	Negative	69 (69.0%)
	Positive	31 (31.0%)
Progesterone receptor	Negative	74 (74.0%)
	Positive	26 (26.0%)
HER2 status	Negative	74 (74.0%)
	Positive	26 (26.0%)
TNBC	No	51 (51.0%)
	Yes	49 (49.0%)
Status	Alive	50 (50.0%)
	Death	35 (35.0%)
	Lost to follow-up	15 (15.0%)
FOXP3	Negative	75 (75.0%)
	Positive	25 (25.0%)
IDO score	Low	24 (24.0%)
	Medium	27 (27.0%)
	High	49 (49.0%)

UNK: Indicates missing data. FOXP3: Forkhead box P3; HER2: Human epidermal growth factor receptor; IDO: Indoleamine 2,3-dioxygenase; TNBC: Triple negative breast cancer; SD: Standard deviation.

Full Size Table

Citation: Asghar K, Loya A, Rana IA, Bakar MA, Farooq A, Tahseen M, Ishaq M, Masood I, Rashid MU. Forkhead box P3 and indoleamine 2,3-dioxygenase co-expression in Pakistani triple negative breast cancer patients. World J Clin Oncol 2020; 11(12): 1018-1028
URL: https://www.wjgnet.com/2218-4333/full/v11/i12/1018.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i12.1018

Asghar K, Loya A, Rana IA, Bakar MA, Farooq A, Tahseen M, Ishaq M, Masood I, Rashid MU. Forkhead box P3 and indoleamine 2,3-dioxygenase co-expression in Pakistani triple negative breast cancer patients. World J Clin Oncol 2020; 11(12): 1018-1028 [PMID: 33437664 DOI: 10.5306/wjco.v11.i12.1018]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.